Abstract

Glycopyrrolate (Robanul - Robins) is promoted as “a new candidate for ‘drug of choice’ in duodenal ulcer,” and it is claimed that “never before has an anticholinergic agent come so close to creating the ideal pharmacological conditions for ulcer healing.” At the same time oxyphencyclimine (Naridan - B.D.H.) has appeared as a “new anticholinergic compound” of “high therapeutic potency and prolonged duration of action.”